Authorized Generic EPCLUSA (sofosbuvir/velpatasvir)

About Asegua Therapeutics

Asegua Therapeutics is a specialized generic pharmaceutical company established as an affiliate of Gilead Sciences to enhance patient access to high-cost hepatitis C treatments. Its core business involves launching and distributing authorized generic versions of Gilead's blockbuster drugs EPCLUSA® and HARVONI®, which are direct-to-generic copies sold under the Asegua label. The company operates within Gilead's ecosystem, leveraging the originator's manufacturing and support infrastructure while offering the drugs at a lower price point. Its mission is strategically aligned with addressing payer and patient affordability concerns in the HCV market.

Therapeutic Areas